Tango Therapeutics Insider Sells $304,000 in Stock Amid a 36% Single-Day Surge
This clinical-stage biotech focused on targeted cancer therapies reported a notable insider sale.
Source: www.fool.com
This clinical-stage biotech focused on targeted cancer therapies reported a notable insider sale.